Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study ID
NCT06536881
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fasting — BEHAVIORAL
    The dietician will review the patient's chemotherapy schedule, and confirm the fasting window (as windows may be 24, 26 or 48 hours; and chemotherapy start times can vary from patient to patient).

Study Details

This research is being done to test the feasibility of 24-48 hours of water-only fasting to improve delivery of 4 cycles of chemotherapy in those receiving breast cancer treatment either before or after surgery.

Key Dates

Start date
Aug 8, 2024
Status verified
Aug 2025
Primary completion
Aug 31, 2028
Completion
May 31, 2029

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
OTHER

Arms

  • Experimental: Fasting prior to chemotherapy
    Prior to chemotherapy administration, a trial of a 24-hour water-only fast will be conducted; at least 1 successful 24-hour fast is required to proceed with the fasting intervention during chemotherapy. A total of 3 trials is allowed (for a maximum of 48 hours fasting).

Primary Outcome Measure

Proportion of participants with self-reported adherence to the fasting regimen [ Time Frame: 6 -8 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sibley Memorial HospitalWashington D.C.District of Columbia20016
Azka Tariq
[email protected]
202-660-5712
Aliya Lalji
[email protected]
202-243-2294

Find similar trials in Washington D.C., DC

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Sibley Memorial Hospital· Washington D.C., DC

Related Studies